DK3510167T3 - Fremgangsmåder og sammensætninger til forudsigelse af kronisk dysfunktion af lungeallotransplantation - Google Patents

Fremgangsmåder og sammensætninger til forudsigelse af kronisk dysfunktion af lungeallotransplantation Download PDF

Info

Publication number
DK3510167T3
DK3510167T3 DK17764388.9T DK17764388T DK3510167T3 DK 3510167 T3 DK3510167 T3 DK 3510167T3 DK 17764388 T DK17764388 T DK 17764388T DK 3510167 T3 DK3510167 T3 DK 3510167T3
Authority
DK
Denmark
Prior art keywords
lunge
allot
transplant
compositions
methods
Prior art date
Application number
DK17764388.9T
Other languages
English (en)
Inventor
Pierre-Joseph Royer
Antoine Magnan
Sophie Brouard
Richard Danger
Original Assignee
Inst Nat Sante Rech Med
Univ Nantes
Ct Hospitalier Universitaire Nantes
Centre Nat Rech Scient
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inst Nat Sante Rech Med, Univ Nantes, Ct Hospitalier Universitaire Nantes, Centre Nat Rech Scient filed Critical Inst Nat Sante Rech Med
Application granted granted Critical
Publication of DK3510167T3 publication Critical patent/DK3510167T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/106Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/112Disease subtyping, staging or classification
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/158Expression markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Pathology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
DK17764388.9T 2016-09-08 2017-09-07 Fremgangsmåder og sammensætninger til forudsigelse af kronisk dysfunktion af lungeallotransplantation DK3510167T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP16306125 2016-09-08
PCT/EP2017/072503 WO2018046615A1 (en) 2016-09-08 2017-09-07 Methods and compositions for predicting chronic lung allograft dysfunction

Publications (1)

Publication Number Publication Date
DK3510167T3 true DK3510167T3 (da) 2021-11-01

Family

ID=56958854

Family Applications (1)

Application Number Title Priority Date Filing Date
DK17764388.9T DK3510167T3 (da) 2016-09-08 2017-09-07 Fremgangsmåder og sammensætninger til forudsigelse af kronisk dysfunktion af lungeallotransplantation

Country Status (6)

Country Link
US (2) US10975438B2 (da)
EP (1) EP3510167B1 (da)
DK (1) DK3510167T3 (da)
ES (1) ES2893482T3 (da)
PT (1) PT3510167T (da)
WO (1) WO2018046615A1 (da)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US12013442B2 (en) * 2018-09-28 2024-06-18 Intel Corporation In-line detection of electrical fails on integrated circuits
WO2022064069A1 (en) * 2020-09-28 2022-03-31 INSERM (Institut National de la Santé et de la Recherche Médicale) Mmp-9 as a predictive marker of chronic allograft dysfunction
CN113234830B (zh) * 2021-06-29 2022-03-08 浙江医院 用于肺癌诊断的产品及用途
EP4177608A1 (en) 2021-11-05 2023-05-10 Medizinische Hochschule Hannover Biomarker panel for diagnosing pulmonary dysfunction

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7741038B2 (en) * 2005-03-14 2010-06-22 The Board Of Trustees Of The Leland Stanford Junior University Methods and compositions for evaluating graft survival in a solid organ transplant recipient
CA2938893C (en) 2013-02-20 2022-12-13 University Health Network Determining a normalized expression of one or more s100a and s100a9 polypeptide expression products for assessing chronic allograft dysfunction

Also Published As

Publication number Publication date
US20210404000A1 (en) 2021-12-30
US11814683B2 (en) 2023-11-14
ES2893482T3 (es) 2022-02-09
EP3510167B1 (en) 2021-08-04
EP3510167A1 (en) 2019-07-17
US20190226027A1 (en) 2019-07-25
WO2018046615A1 (en) 2018-03-15
US10975438B2 (en) 2021-04-13
PT3510167T (pt) 2021-10-18

Similar Documents

Publication Publication Date Title
DK3842442T3 (da) Sammensætninger og fremgangsmåder til hæmning af arginaseaktivitet
DK3212778T3 (da) Fremgangsmåder og sammensætninger til stabilisering af trans-splejsning af intein-modificerede proteaser
DK3368541T3 (da) Sammensætninger og metoder til inhibiering af arginaseaktivitet
DK3484469T3 (da) Sammensætninger og fremgangsmåder til potentiering af antimikrober
DK3282836T3 (da) Fremgangsmåde til opdræt af insekter
DK3110975T3 (da) Fremgangsmåder til analyse af somatiske mobile elementer og anvendelser deraf
DK3277717T3 (da) En hidtil ukendt il33-form, muterede former af il33, antistoffer, assays og fremgangsmåder til anvendelse deraf
DK3256604T3 (da) Fremgangsmåder og sammensætninger til analyse af cellebestanddele
DK3423451T3 (da) Inhibitorer af wdr5-protein-proteinbinding
DK3148579T3 (da) Anti-gitr antistoffer og fremgangsmåder til anvendelse deraf
DK3292134T3 (da) Metode til dyrkning af akkermansia
DK3152312T3 (da) Fremgangsmåder og sammensætninger til modifikation af et mållocus
DK3316909T3 (da) Anti-ntb-a-antistoffer og relaterede sammensætninger og fremgangsmåder
DK3250210T3 (da) Sammensætninger og fremgangsmåder til behandling af cns-forstyrrelser
DK3484916T3 (da) Antistoffer specifikke for hyperphosphoryleret tau og fremgangsmåder til anvendelse deraf
DK3519572T3 (da) Forbindelser og fremgangsmåder til reduktion af tau-ekspression
DK3250610T3 (da) Fcrn-antistoffer og fremgangsmåder til anvendelse heraf
DK3144001T3 (da) Sammensætninger af selenoorganiske forbindelser og fremgangsmåder til anvendelse deraf
DK3399985T3 (da) Sammensætninger og biblioteker, der omfatter rekombinante T-cellereceptorer, og fremgangsmåder til anvendelse af rekombinante T-cellereceptorer
DK3393655T3 (da) Fenfluramin-sammensætninger og fremgangsmåder til fremstilling af samme
DK3071215T3 (da) Sammensætninger og fremgangsmåder til behandling af pulmonal hypertension
DK3319948T3 (da) Acesulfam-kaliumsammensætninger og fremgangsmåder til fremstilling af disse
DK3322695T3 (da) Acesulfam-kalium-sammensætninger og fremgangsmåder til fremstilling af disse
DK3280440T3 (da) Humaniserede anti-c1s-antistoffer og fremgangsmåder til anvendelse deraf
DK3394259T3 (da) Sammensætninger og fremgangsmåder til reducering af tau-ekspression